My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Amazon Stock Enters 'Prove It Mode': Analysts...
AI Is Not Driving Widespread Job Losses, Goog...
Tesla Eyes US Solar Cell Expansion, Musk Targ...
Inflation Worries Drop To Lowest Level Since...
Alphabet Q4 Earnings Win Over Analysts: 'We H...
Stellantis Stock Tanks After Loss Alert, Mass...
From AI Darlings To Old Economy? Why Investor...
Reddit Stock Seesaws On Q4 Earnings Beat, $1...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    MAINZ BIOMED N V (NASDAQ: MYNZ)

    Overview
    current price
    $0.95
    $0.95
    change
    -0.04 | -4.51%
    -0.04 | -4.51%
    Yesterday's Close
    0.99
    open
    1.00
    volume
    0.26 M
    30d. avg volume.
    0.47 M
    1 day
    0.92 - 1.04
    52 weeks
    0.92 - 8.16
    p/e
    0.00
    beta
    0.2633
    market cap
    0.01 B
    dividend yield
    0.00%
    Industry
    -
    MYNZ by TradingView
    News and Commentary
    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (PFE 
    Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to rebuild their business, pharmaceutical companies like Pfizer...
    mRNA Is Promising A Breakthrough In Fighting Cancer When it comes to cancer, there's innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during...
    The Pharmaceutical Industry Finds Itself At A Historical Crossroads Bristol Myers Squibb (BMY
    2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front On Thursday, Merck & Co Inc (M...
    Pharma Continues Its Ongoing Battle Against Cancer Last Tuesday, Pfizer Inc (PFE
    Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine Johnson & Johnson (JNJ&...
    German Medical Companies Led 12 IPO Week November's initial public offering (IPO) market started off strong, with 12 traditional offering raising over $2 billion. However, the week ahead is expected to be explosive, wit...
    November IPO Market Starts Hot with 12 Listings Planning to Raise $3.2 Billion in the Week Ahead The initial public offering (IPO) market plans to extend its momentum heading into November, with 12 traditional offers expected to raise nearly $3.2 billion.
    StockTwits
    StockTwits
    Most Shared
    Amazon Defends Massive AI Spending, Says New AWS Capacity Being Monetized Quickly: Andy Jassy Sees Very 'Unusual' Opportunity
    US Consumer Sentiment Hits 5-Month Highs As Inflation Worries Fall To 1-Year Low
    Elon Musk's $1.25 Trillion SpaceX-xAI Merger Reportedly Designed To Protect IPO Timeline While Minimizing Financial Risk: Here's How
    Most Popular
    Sam Altman To Host AI Town Hall — Asks Builders To Submit Questions As OpenAI Begins To Build 'New Generation Of Tools'
    Nvidia Is Bank of America's Top Chip Pick: AI Demand, Pricing Power Drive Growth
    Costco Holiday Blowout Signals Strong Stock Recovery Ahead: Analyst
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    Covid-19
    China
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?